
Red Cat Holdings Reports Financial Results For Fiscal Second Quarter 2025 And Provides Corporate Update
RED CAT HOLDINGS | |||||||||
Condensed Consolidated Balance Sheets | |||||||||
October 31, | April 30, | ||||||||
2024 | 2024 | ||||||||
ASSETS | |||||||||
Cash and marketable securities | $ | 4,611,092 | $ | 6,067,169 | |||||
Accounts receivable, net | 1,121,398 | 4,361,090 | |||||||
Inventory, including deposits | 12,554,330 | 8,610,125 | |||||||
Intangible assets including goodwill, net | 26,403,796 | 12,882,939 | |||||||
Other | 6,401,772 | 7,473,789 | |||||||
Equity method investee | - | 5,142,500 | |||||||
Note receivable | - | 4,000,000 | |||||||
TOTAL ASSETS | $ | 51,092,388 | $ | 48,537,612 | |||||
LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||||
Accounts payable and accrued expenses | $ | 3,244,776 | $ | 2,703,922 | |||||
Debt obligations | 356,964 | 751,570 | |||||||
Operating lease liabilities | 1,551,316 | 1,517,590 | |||||||
Convertible notes payable | 11,911,307 | - | |||||||
Acquisition consideration payable | 7,000,000 | - | |||||||
Total liabilities | 24,064,363 | 4,973,082 | |||||||
Stockholders' capital | 133,909,751 | 124,690,641 | |||||||
Accumulated deficit/comprehensive loss | (106,881,726 | ) | (81,126,111 | ) | |||||
Total stockholders' equity | 27,028,025 | 43,564,530 | |||||||
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $ | 51,092,388 | $ | 48,537,612 | |||||
Condensed Consolidated Statements of Operations | ||||||||||||||||
Three months ended October 31, | Six months ended October 31, | |||||||||||||||
2024 | 2023 | 2024 | 2023 | |||||||||||||
Revenues | $ | 1,534,727 | $ | 3,930,868 | $ | 4,311,262 | $ | 5,678,997 | ||||||||
Cost of goods sold | 1,558,202 | 2,730,286 | 4,818,128 | 4,303,750 | ||||||||||||
Gross (loss) profit | (23,475 | ) | 1,200,582 | (506,866 | ) | 1,375,247 | ||||||||||
Operating Expenses | ||||||||||||||||
Research and development | 2,231,470 | 2,222,137 | 3,857,910 | 3,575,688 | ||||||||||||
Sales and marketing | 2,343,779 | 1,032,645 | 4,385,290 | 2,321,405 | ||||||||||||
General and administrative | 4,517,695 | 2,838,080 | 8,000,790 | 5,701,838 | ||||||||||||
Impairment loss | - | - | 93,050 | - | ||||||||||||
Total operating expenses | 9,092,944 | 6,092,862 | 16,337,040 | 11,598,931 | ||||||||||||
Operating loss | (9,116,419 | ) | (4,892,280 | ) | (16,843,906 | ) | (10,223,684 | ) | ||||||||
Other (income) expense | ||||||||||||||||
Convertible notes payable fair value adjustment | 4,230,307 | - | 4,230,307 | - | ||||||||||||
Loss on sale of equity method investment | - | - | 4,008,357 | - | ||||||||||||
Equity method loss | - | - | 734,143 | - | ||||||||||||
Investment loss, net | - | 333,867 | - | 573,357 | ||||||||||||
Interest (income) expense, net | (14,634 | ) | 19,696 | (39,188 | ) | 41,553 | ||||||||||
Other, net | 2,526 | (1,544 | ) | (26,531 | ) | - | ||||||||||
Other expense | 4,218,199 | 352,019 | 8,907,088 | 614,910 | ||||||||||||
Net loss from continuing operations | (13,334,618 | ) | (5,244,299 | ) | (25,750,994 | ) | (10,838,594 | ) | ||||||||
Loss from discontinued operations | - | (599,511 | ) | - | (842,084 | ) | ||||||||||
Net loss | $ | (13,334,618 | ) | $ | (5,843,810 | ) | $ | (25,750,994 | ) | $ | (11,680,678 | ) | ||||
Loss per share - basic and diluted | $ | (0.18 | ) | $ | (0.11 | ) | $ | (0.34 | ) | $ | (0.21 | ) | ||||
Weighted average shares outstanding - basic and diluted | 76,184,777 | 55,606,336 | 75,342,629 | 55,270,838 |
Condensed Consolidated Statements of Cash Flows | ||||||||
Six months ended October 31, | ||||||||
2024 | 2023 | |||||||
Cash Flows from Operating Activities | ||||||||
Net loss from continuing operations | $ | (25,750,994 | ) | $ | (10,838,594 | ) | ||
Non-cash expenses | 12,662,208 | 3,411,397 | ||||||
Changes in operating assets and liabilities | 601,073 | (3,813,162 | ) | |||||
Net cash used in operating activities | (12,487,713 | ) | (11,240,359 | ) | ||||
Cash Flows from Investing Activities | ||||||||
Proceeds from sale of equity method investment and note receivable | 4,400,000 | - | ||||||
Proceeds from sale of marketable securities | - | 10,205,501 | ||||||
Other | (123,793 | ) | (139,860 | ) | ||||
Net cash provided by investing activities | 4,276,207 | 10,065,641 | ||||||
Cash Flows from Financing Activities | ||||||||
Proceeds from issuance of convertible notes payable, net | 7,681,000 | - | ||||||
Payments of debt obligations, net | (394,606 | ) | (279,126 | ) | ||||
Payments related to employee equity transactions | (530,965 | ) | (16,292 | ) | ||||
Proceeds from issuance of common stock through ATM facility, net | - | 9,212 | ||||||
Net cash used in financing activities | 6,755,429 | (286,206 | ) | |||||
Net cash used in discontinued operations | - | (384,094 | ) | |||||
Net decrease in Cash | (1,456,077 | ) | (1,845,018 | ) | ||||
Cash, beginning of period | 6,067,169 | 3,260,305 | ||||||
Cash, end of period | 4,611,092 | 1,415,287 | ||||||
Less: Cash of discontinued operations | - | (6,310 | ) | |||||
Cash of continuing operations, end of period | 4,611,092 | 1,408,977 | ||||||
Marketable securities | - | 2,615,289 | ||||||
Cash of continuing operations and marketable securities | $ | 4,611,092 | $ | 4,030,576 | ||||


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.
Comments
No comment